ArticleCureus2026
Suspected Secondary Intraocular Lymphoma With Choroidal Involvement Following Testicular Diffuse Large B-cell Lymphoma: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Secondary intraocular lymphoma is an uncommon manifestation of systemic lymphoma and may relapse in immune-privileged sites years after apparent remission. We report the case of a 67-year-old man with a history of right testicular diffuse large B-cell lymphoma (DLBCL) treated with orchiectomy and systemic chemotherapy who presented five years later with painless progressive vision loss in the left eye. Examination revealed visual acuity of 20/80, fibrinoid material with hemorrhage in the anterior chamber, and yellow-white choroidal infiltrates extending from the optic disc toward the periphery with associated subretinal fluid. Multimodal imaging demonstrated subretinal infiltrates and diffuse choroidal thickening. Diagnostic pars plana vitrectomy was performed during repair of an associated retinal detachment. Routine cytology was nondiagnostic, MYD88 L265P testing was negative, and flow cytometry using a limited panel identified an abnormal lambda-restricted B-cell population comprising 45.2% of CD45+ events, without definitive morphologic confirmation. In the context of the patient's prior lymphoma history, supportive multimodal ocular findings, and exclusion of major infectious and inflammatory etiologies, the overall clinicopathologic impression favored secondary intraocular lymphoma with choroidal involvement. Systemic restaging showed no active extraocular or central nervous system disease. Treatment with oral ibrutinib 560 mg daily was associated with clinical stability over 24 months, improvement of visual acuity to 20/40, resolution of subretinal fluid, stable residual choroidal changes, and no evidence of systemic recurrence. This case highlights the importance of long-term ophthalmic surveillance in patients with testicular DLBCL and the integration of multimodal imaging, ocular fluid analysis, and systemic restaging in the evaluation of suspected ocular relapse.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.